HN
$98.63
+0.96
(+0.98%)
As of Oct 5, 2026, 3:44 PM EDT · cached
Price history
Hinge Health (HNGE) is trading up at $98.63 (+0.98%), as of the latest quote. It is a Russell 2000 constituent in the Health Care sector.
IPO: May 22, 2025 · $32.00 offering · NYSE · View IPO details →
Hinge Health revenue & net income history (FY2023–FY2025)
RevenueNet income
| FY2023Dec 2023 | FY2024Dec 2024 | FY2025Dec 2025 | |
|---|---|---|---|
| Income statement | |||
| Revenue | $292.7M | $390.4M | $587.9M |
| Growth (year over year) | — | +33.4% | +50.6% |
| Gross profit | $194.2M | $299.9M | $468.2M |
| Gross margin | 66.3% | 76.8% | 79.6% |
| Operating income | −$130.5M | −$31.9M | −$546.4M |
| Operating margin | −44.6% | −8.2% | −92.9% |
| Net income | −$108.1M | −$11.9M | −$528.3M |
| Net margin | −36.9% | −3.1% | −89.9% |
| EPS (diluted) | −$8.31 | −$0.88 | −$7.77 |
| Balance sheet | |||
| Cash and equivalents | $235.0M | $300.8M | $208.0M |
| Total assets | — | $673.3M | $744.8M |
| Total liabilities | — | $256.6M | $366.2M |
| Shareholders' equity | −$424.0M | −$434.6M | $178.7M |
| Cash flow | |||
| Operating cash flow | −$63.9M | $49.0M | $171.4M |
| Capital expenditure | $1.98M | $1.04M | $708.0K |
| Free cash flow | −$65.9M | $48.0M | $170.7M |
| Share buybacks | $0 | $0 | $65.0M |
RevenueNet income
| Q3 FY24Sep 2024 | Q4 FY24†Dec 2024 | Q1 FY25Mar 2025 | Q2 FY25Jun 2025 | Q3 FY25Sep 2025 | Q4 FY25†Dec 2025 | Q1 FY26Mar 2026 | Q2 FY26Jun 2026 | |
|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||
| Revenue | $100.6M | $117.3M | $123.8M | $139.1M | $154.2M | $170.7M | $182.3M | $212.8M |
| Growth (year over year) | — | — | +49.7% | +54.9% | +53.3% | +45.6% | +47.2% | +53.0% |
| Gross profit | $79.3M | $96.1M | $100.2M | $97.8M | $126.2M | $144.0M | $154.2M | $183.9M |
| Gross margin | 78.8% | 81.9% | 80.9% | 70.3% | 81.8% | 84.4% | 84.6% | 86.4% |
| Operating income | −$3.85M | $20.9M | $13.1M | −$580.7M | −$6.09M | $27.3M | $32.1M | $40.4M |
| Operating margin | −3.8% | 17.8% | 10.6% | −417.5% | −4.0% | 16.0% | 17.6% | 19.0% |
| Net income | $341.0K | $27.1M | $17.1M | −$575.7M | −$1.84M | $32.1M | $35.1M | $43.7M |
| Net margin | 0.3% | 23.1% | 13.8% | −413.8% | −1.2% | 18.8% | 19.3% | 20.5% |
| EPS (diluted) | $0.01 | $2.04 | $1.31 | −$13.10 | −$0.02 | $4.04 | $0.41 | $0.52 |
| Balance sheet | ||||||||
| Cash and equivalents | $267.5M | $300.8M | $288.5M | $237.2M | $261.3M | $208.0M | $186.7M | $286.2M |
| Total assets | — | $673.3M | — | $693.7M | $769.8M | $744.8M | $728.8M | $827.4M |
| Total liabilities | — | $256.6M | — | $320.0M | $361.9M | $366.2M | $417.2M | $483.1M |
| Shareholders' equity | −$461.8M | −$434.6M | −$308.3M | $173.8M | $208.0M | $178.7M | $111.7M | $344.3M |
| Cash flow | ||||||||
| Operating cash flow | $28.4M | $38.3M | $4.92M | $20.2M | $82.4M | $63.9M | $43.1M | $101.4M |
| Capital expenditure | $315.0K | $157.0K | $51.0K | $197.0K | $52.0K | $408.0K | $83.0K | $123.0K |
| Free cash flow | $28.1M | $38.2M | $4.87M | $20.0M | $82.3M | $63.5M | $43.0M | $101.3M |
| Share buybacks | — | — | $0 | $0 | — | — | $105.0M | $26.5M |
From Hinge Health's 10-K and 10-Q filings with the SEC; its fiscal year ends in December. Each period shows the latest figure the company has reported for it, including restatements. † Quarter derived from the company's year-to-date or full-year totals. Filings on SEC EDGAR →
About Hinge Health
- Headquarters
- San Francisco, California From SEC filings, Oct 2026
Recent News (2)
Other Health Care companies to compare with HNGE
- HCAT Health Catalyst Inc
- HCM HUTCHMED
- HCWB HCW Biologics
- HIMS Hims Hers Health Inc Class a
- HOWL Werewolf Therapeutics
- HQY Healthequity Inc
- HRMY Harmony Biosciences Hldg Inc
- HROW Harrow Inc